drugset / Trial / NCT01760499
Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study
Phase 1
Completed
15 enrolled
H. Lee Moffitt Cancer Center and Research Institute
Provectus Pharmaceuticals · collab
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to find out more about how PV-10 works in melanoma tumors. Researchers also want to find out if there are changes in the body's immune cells (cells that fight infection and illnesses) after PV-10 is given, both inside the melanoma tumors and circulating in the blood.
Timeline
- Start
- 2013-01-24
- Primary completion
- 2015-12-29
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PV-10 | Unknown | — | Other |